RecruitingNot ApplicableNCT07678697

Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique

Comparative Study Between Nd:YAG Laser Combined With Injection Sclerotherapy Versus Diode Laser in the Treatment of Reticular Veins and Telangiectasias Using CLaCS Technique

Sponsor

Ain Shams University

Enrollment

80 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

Sclerotherapy Nd:YAG Laser Diode Laser Reticular Veins Telangiectasias CLaCS Technique

Summary

This study aims to compare the efficacy (in terms of vein clearance) and safety of Nd:YAG laser combined with injection sclerotherapy versus diode laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias using the Cryo-Laser and Cryo-Sclerotherapy (CLaCS) technique.

Eligibility

Min Age: 18 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Diode laser and a medical device called Nd:YAG laser for people with clacs technique, diode laser, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICENd:YAG laser

Patients will receive Nd:YAG laser (1064 nm) + injection sclerotherapy (CLaCS).

DRUGDiode laser

Patients will receive Diode laser (980 nm) + injection sclerotherapy (CLaCS).

Locations(1)

Ain Shams University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07678697

Related Trials

Ethanol Sclerotherapy Prior to ART

NCT059627753 locations